Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
  1. 4 Open-market sale Chief Financial Officer sold 6,476 shares at $4.24 ($27,458)
  2. 4 Open-market sale General Counsel sold 6,181 shares at $4.24 ($26,207)
  3. 4 Open-market sale President and CEO sold 19,669 shares at $4.24 ($83,397)
  4. 4 Grant or award Chief Business Officer acquired 44,444 shares (grant or award)
  5. 4 Grant or award General Counsel acquired 55,556 shares (grant or award)
  6. 4 Grant or award Chief Medical Officer acquired 55,556 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 55,556 shares (grant or award)
  8. 4 Grant or award President and CEO acquired 176,300 shares (grant or award)
  9. 4 Open-market buy 10% owner bought 7,328 shares at $3.50 ($25,648)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy 10% owner bought 20,000 shares at an average $3.95 ($78,975)
  13. 4 Open-market buy 10% owner bought 150,000 shares at an average $4.59 ($689,230)
  14. 4 Grant or award Chief Medical Officer acquired 6,667 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Director acquired 8,933 shares (grant or award)
  17. 4 Grant or award Director acquired 8,933 shares (grant or award)
  18. 4 Grant or award Director acquired 8,933 shares (grant or award)
  19. 4 Grant or award Director acquired 8,933 shares (grant or award)
  20. 4 Grant or award Director acquired 8,933 shares (grant or award)

Page 8 of 18 · 354 filings